greeksoup/ stock research
Stock research / United States / SNY / Year to 31 December 2024

Sanofi (SNY) annual results, year to 31 December 2024: revenue EUR 41,081 million, from the 20-F

Sanofi files a 20-F with the SEC once a year, in euros. In the year to 31 December 2024 it reported revenue from the sale of goods of EUR 41,081 million ($44.4 billion at the year's average rate), up 8.6% on the year before. Its profit attributable to shareholders was EUR 5,560 million, up 3.0%, and diluted earnings per share EUR 4.43.

Revenue
EUR 41,081 million
+8.6% on the year
FY2017FY2024
Operating margin
17.7%
18.4% a year earlier
FY2017FY2024
Net income
EUR 5,560 million
+3.0% on the year
FY2017FY2024
Diluted EPS
EUR 4.43
+3.0% on the year
FY2017FY2024

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2023 †Dec 2024
Revenue from the sale of goods37,81741,081
Cost of sales12,62813,205
Gross profit28,99031,081
Research and development6,5077,394
Selling, general and administrative8,9339,183
Operating profit6,9607,252
Finance costs1,2931,073
Income tax1,0171,204
Profit for the year5,4365,618
Profit attributable to shareholders5,4005,560
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2023 †Dec 2024
Diluted EPS4.304.43
Basic EPS4.314.44
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2023 †Dec 2024
Cash from operations10,2589,081
Cash from investing-6,200-4,407
Cash from financing-8,052-5,763
Buybacks593302
Dividends paid4,4544,704
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2023 †Dec 2024
Funded by
Equity attributable to shareholders74,04077,507
Non-controlling interests313350
Borrowings, as filed16,53116,137
Lease liabilities2,0301,906
Other liabilities33,55036,898
Total equity and liabilities126,464132,798
Owned
Property, plant and equipment10,16010,091
Goodwill49,40443,384
Other intangible assets24,31922,629
Cash and cash equivalents8,7107,441
Inventories9,6669,431
Other assets24,20539,822
Total assets126,464132,798
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2023 †Dec 2024
Return on year-end equity7.3%7.2%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2024, filed 17 February 2026: the filing. The figures are in euros as filed.